Oxford Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Oxford Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,009	Closed	-$309K	–	1178
2019 Q4	$309K	Buy	+13,009	New	+$316K	0.01%	1426
2019 Q2	–	Sell	-97,242	Closed	-$3.41M	–	1952
2019 Q1	$3.41M	Buy	97,242 +50,866	+110%	+$1.89M	0.07%	332
2018 Q4	$1.54M	Buy	+46,376	New	+$1.99M	0.04%	622
2018 Q2	–	Sell	-28,015	Closed	-$1.28M	–	1915
2018 Q1	$1.28M	Sell	28,015 -24,446	-47%	-$1.02M	0.03%	812
2017 Q4	$2.12M	Buy	52,461 +28,703	+121%	+$1.13M	0.05%	541
2017 Q3	$947K	Buy	+23,758	New	+$1.03M	0.02%	958
2017 Q2	–	Sell	-68,285	Closed	-$2.14M	–	1698
2017 Q1	$2.14M	Buy	68,285 +37,041	+119%	+$993K	0.05%	444
2016 Q4	$789K	Sell	31,244 -98,581	-76%	-$2.2M	0.03%	516
2016 Q3	$3.21M	Sell	129,825 -148,843	-53%	-$3.37M	0.1%	276
2016 Q2	$5.68M	Sell	278,668 -62,958	-18%	-$1.12M	0.19%	121
2016 Q1	$5.21M	Sell	341,626 -49,368	-13%	-$644K	0.15%	152
2015 Q4	$5.35M	Buy	390,994 +110,028	+39%	+$1.7M	0.13%	170
2015 Q3	$3.94M	Sell	280,966 -430,163	-60%	-$8M	0.12%	172
2015 Q2	$12.1M	Buy	711,129 +638,190	+875%	+$9.08M	0.33%	53
2015 Q1	$882K	Buy	+72,939	New	+$689K	0.02%	479

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Oxford Asset Management's SUPN Position: Q1 2020 in Review

Oxford Asset Management sold out of Supernus Pharmaceuticals (SUPN) in Q1 2020, closing a stake of 13,009 shares — an estimated $309K sold.

Oxford Asset Management first reported a position in SUPN in Q1 2015 and held it in 15 quarters. The position peaked at $12.1M in Q2 2015. 208 funds tracked by Wall St. Rank hold SUPN as of Q1 2020.

Oxford Asset Management reported no remaining Supernus Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 13,009 Supernus Pharmaceuticals shares in Q1 2020, an estimated $309K.
Oxford Asset Management first reported a position in Supernus Pharmaceuticals in Q1 2015 and held it in 15 quarters.
Oxford Asset Management's Supernus Pharmaceuticals position peaked at $12.1M in Q2 2015.
208 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.